Israeli-based Selector rounded off a disappointing year in suitable fashion as losses increased to $774,000 ($179,000) on reduced sales of $1.3m ($1.4m). Eleven months ago the company entered into a heads of agreement with Nasdaq-listed Healthcare Technologies, which would have seen it be reversed into by two of the latter's subsidiaries. This deal fell apart in April however, because the subsidiaries were unable to raise the necessary capital. As if to make matters worse the company has been forced to make a $205,000 provision against stock, described by the board as being effectively 'worthless'.